Skip to main content

Table 2 Patient characteristics at T0

From: Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial

Characteristics at T0

Intervention group

Control group

 

(N =552)

(N = 568)

Age mean (SD)

63.8 (± 12.1)

65.0 (± 12.4)

Gender: male % (N)

46.7% (258)

44.7% (254)

Educational level (Total valid N)

(523)

(521)

 low

62.7% (328)

63.8% (332)

 middle

24.1% (126)

22.6% (118)

 high

13.2% (69)

13.6% (71)

ABDM (Total valid N)

(552)

(568)

 24h-mean systolic (SD)

133.19 (13.58)

130.80 (12.62)

 24h-mean diastolic (SD)

81.98 (9.77)

79.29 (9.74)

Uncontrolled hypertension

90.8% (501)

84.7% (481)

1 Comorbidity

41.1% (227)

48.8% (277)

 Diabetes mellitus

23.7% (131)

32.6% (185)

 Heart attack / CHD

16.8% (93)

20.8% (118)

 Stroke/ TIA

4.7% (26)

5.5% (31)

 Peripheral arterial occlusive disease

3.6% (20)

4.1% (23)

Manifest arteriosclerosis (heart attack, CHD, stroke, TIA, or PAOD)

22.6% (125)

26.4% (150)

CVR score in % (Total valid N)

(420)

(377)

 Mean (SD)

20.40 (± 19.1)

22.85 (± 18.71)

BMI (Total valid N)

(545)

(561)

 Mean (SD)

28.58 (± 4.78)

28.58 (± 4.79)

Smoking (Total valid N)

(544)

(558)

 Positive (N)

11.2% (861)

11.6% (65)

Family history of CVD (Total valid N)

(528)

(527)

Positive (N)

24.2% (128)

19.4% (102)

Treatment outside the GP praxis

35.3% (195)

35.0% (199)

SDM-Q-9* (Total valid N)

(451)

(489)

 Mean (SD)

73.00 (± 17.66)

70.67 (± 20.24)

Intention-to-treat-hypertension scale* (Total valid N)

(521)

(527)

 Mean (SD)

80.61 (± 13.32)

79.79 (± 13.52)

MARS-D*(Total valid N)

(531)

(539)

 Mean (SD)

93.9 (± 9.8)

93.5 (± 10.1)

Knowledge* (Total valid N)

(536)

(547)

 Mean (SD)

46.63 (± 27.60)

44.22 (± 28.64)

  1. * Scale 0 – 100 (0 = lowest level and 100 = highest level).
  2. ABPM ambulatory blood pressure monitoring, CHD coronary heart disease, TIA transient ischemic attack, PAOD peripheral arterial occlusive disease, CVR cardiovascular risk, BMI Body Maas Index, CVD, cardiovascular disease, SDM-Q-9 Shared Decision Making-Questionnaire, MARS-D Medication Adherence Report Scale-German Version.